These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21542673)

  • 1. Increased incidence of oropharyngeal cancer and p16 expression.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2011 Sep; 131(9):1008-11. PubMed ID: 21542673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
    Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
    Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV status and second primary tumours in oropharyngeal squamous cell carcinoma.
    Xu CC; Biron VL; Puttagunta L; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 May; 42(1):36. PubMed ID: 23718873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16
    Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland.
    Jouhi L; Halme E; Irjala H; Saarilahti K; Koivunen P; Pukkila M; Hagström J; Haglund C; Lindholm P; Hirvikoski P; Vaittinen S; Ellonen A; Tikanto J; Blomster H; Laranne J; Grénman R; Mäkitie A; Atula T
    Acta Oncol; 2018 Apr; 57(4):541-551. PubMed ID: 29145765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
    Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
    ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
    Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma.
    Saito Y; Yoshida M; Ushiku T; Omura G; Ebihara Y; Shimono T; Fukayama M; Yamasoba T; Asakage T
    Cancer; 2013 Jun; 119(11):2005-11. PubMed ID: 23504914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptima HR-HPV Testing of Cytology Specimens Is an Effective Supplement for p16 Staining to Improve Diagnostic Accuracy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
    Yang X; Hu C; Zhao H; Zhang Z; Zhao L; Yu J; Ni X; Guo H
    Acta Cytol; 2023; 67(3):321-332. PubMed ID: 36513056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
    Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
    Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
    Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.